← Back to all trials
Recruiting
NCT05753969
The Efficacy of "Mindtesion"is Measuring Attentional and the Startle Response Dysregulation in Children and Adolescents Suffering From Attention Deficit Disorder: With and Without Medication.
Conditions: Attention Deficit Disorder With Hyperactivity
Sex: All
Ages: 7 Years – 18 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 200
Sponsor: Geha Mental Health Center
Location: Israel
Summary
Double blind, placebo-controlled clinical study designed to evaluate Mindtension device and Protocol as a diagnostic tool in children diagnosed with ADHD
Eligibility Criteria
Inclusion Criteria:(i) Children with ADHD according to DSM-5 criteria in a semi-structured interview by a senior psychiatrist.(ii) Reaching 85 percent score on the ADHD-RS scale.
(iii) Treated with a stimulant in the perceived optimal dosage.Exclusion Criteria:(i) autism spectrum disorder.
(ii) chronic neurological disorders and chronic medical conditions (e.g., diabetes).(iii) schizophrenia spectrum and other psychotic disorders.
(iv) substance abuse (drugs or alcohol).
(v) depression.
(vi) hearing loss.
(vii) lack of cooperation.
Source: ClinicalTrials.gov (NCT05753969). StuddyBuddy aggregates publicly available trial information.
